$CBFV
CB Financial Services, Inc. Stock $cbfv

$cbfv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000160530123000024 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$15.20M	$14.24M
YoY Change	38.74%	34.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$710.0K	$710.0K
YoY Change	10.08%	11.46%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$4.083M	$2.661M
YoY Change	413.58%	268.05%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$3.456M	$5.285M
YoY Change	4570.27%	37.27%
Income Tax	$699.0K	$1.129M
% Of Pretax Income	20.23%	21.36%
Net Earnings	$2.757M	$4.156M
YoY Change	2236.44%	36.4%
Net Earnings / Revenue	18.13%	29.18%
Basic Earnings Per Share	$0.54	$0.81
Diluted Earnings Per Share	$0.54	$0.81
COMMON SHARES
Basic Shares Outstanding	5.110M shares	5.121M shares
Diluted Shares Outstanding	5.116M shares	5.116M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$78.09M	$103.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$18.58M	$17.73M
YoY Change	-7.1%	-3.36%
Goodwill	$9.732M	$9.732M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.433B	$1.431B
YoY Change	3.34%	-0.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.20M	$15.21M
YoY Change	183.81%	105.58%
Accrued Expenses	$1.900M	$2.013M
YoY Change	-4.76%	1.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$121.0K
YoY Change	-100.0%	-99.69%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$18.10M	$17.35M
YoY Change	134.97%	85.01%
LONG-TERM LIABILITIES
Long-Term Debt	$14.70M	$14.65M
YoY Change	0.56%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$14.70M	$14.65M
YoY Change	0.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.10M	$17.35M
Total Long-Term Liabilities	$14.70M	$14.65M
Total Liabilities	$1.316B	$1.314B
YoY Change	3.41%	-0.23%
SHAREHOLDERS EQUITY
Retained Earnings	$70.31M	$68.83M
YoY Change		15.99%
Common Stock	$2.389M	$2.388M
YoY Change		0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$13.93M
YoY Change		12.61%
Treasury Stock Shares		614.1K shares
Shareholders Equity	$116.6M	$117.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.433B	$1.431B
YoY Change	3.34%	-0.55%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$2.757M	$4.156M
YoY Change	2236.44%	36.4%
Depreciation, Depletion And Amortization	$710.0K	$710.0K
YoY Change	10.08%	11.46%
Cash From Operating Activities	$1.310M	$7.231M
YoY Change	-37.47%	128.47%
INVESTING ACTIVITIES
Capital Expenditures	$1.150M	$204.0K
YoY Change	-1613.16%	9.68%
Acquisitions
YoY Change
Other Investing Activities	-$25.85M	-$10.86M
YoY Change	5274.22%	-40.57%
Cash From Investing Activities	-$27.00M	-$11.06M
YoY Change	4747.4%	-40.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	250.0K	$3.673M
YoY Change	-100.57%	-80.87%
NET CHANGE
Cash From Operating Activities	1.310M	$7.231M
Cash From Investing Activities	-27.00M	-$11.06M
Cash From Financing Activities	250.0K	$3.673M
Net Change In Cash	-25.44M	-$155.0K
YoY Change	-40.09%	-103.96%
FREE CASH FLOW
Cash From Operating Activities	$1.310M	$7.231M
Capital Expenditures	$1.150M	$204.0K
Free Cash Flow	$160.0K	$7.027M
YoY Change	-92.63%	135.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001605301
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#InterestReceivableAndOtherAssets
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36706
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CB FINANCIAL SERVICES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0534721
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 N. Market Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmichaels
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	15320
CY2023Q1	dei	City Area Code CityAreaCode	724
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	966-5041
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.4167 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CBFV
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5110038	shares
CY2023Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	85533000	usd
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	82957000	usd
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	18012000	usd
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	20743000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103545000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103700000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	186559000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	187360000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2466000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2698000	usd
CY2023Q1	cbfv	Available For Sale Debt And Marketable Equity Securities AvailableForSaleDebtAndMarketableEquitySecurities	189025000	usd
CY2022Q4	cbfv	Available For Sale Debt And Marketable Equity Securities AvailableForSaleDebtAndMarketableEquitySecurities	190058000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	10270000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	12819000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1061595000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1037054000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17732000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17844000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	24943000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	25893000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	9732000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9732000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3068000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3513000	usd
CY2023Q1	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	21068000	usd
CY2022Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	21144000	usd
CY2023Q1	us-gaap	Assets Assets	1430708000	usd
CY2022Q4	us-gaap	Assets Assets	1408938000	usd
CY2023Q1	us-gaap	Demand Deposit Accounts DemandDepositAccounts	350911000	usd
CY2022Q4	us-gaap	Demand Deposit Accounts DemandDepositAccounts	390405000	usd
CY2023Q1	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	359051000	usd
CY2022Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	311825000	usd
CY2023Q1	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	206174000	usd
CY2022Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	209125000	usd
CY2023Q1	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	234935000	usd
CY2022Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	248022000	usd
CY2023Q1	us-gaap	Time Deposits TimeDeposits	130449000	usd
CY2022Q4	us-gaap	Time Deposits TimeDeposits	109126000	usd
CY2023Q1	us-gaap	Deposits Deposits	1281520000	usd
CY2022Q4	us-gaap	Deposits Deposits	1268503000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	121000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8060000	usd
CY2023Q1	us-gaap	Other Borrowings OtherBorrowings	14648000	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	14638000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	17224000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7582000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1313513000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1298783000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.4167
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.4167
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5730908	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5116830	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5708433	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5100189	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2388000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2379000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84118000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83953000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	68834000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	63861000	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	614078	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	608244	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	13927000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	13797000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24218000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26241000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117195000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	110155000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1430708000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1408938000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12371000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	9551000	usd
CY2023Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	964000	usd
CY2022Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	905000	usd
CY2023Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	41000	usd
CY2022Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	66000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	24000	usd
CY2022Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	22000	usd
CY2023Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	844000	usd
CY2022Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	72000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14244000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10616000	usd
CY2023Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2504000	usd
CY2022Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	530000	usd
CY2023Q1	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	2000	usd
CY2022Q1	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	19000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	155000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	174000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2661000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	723000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11583000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9893000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	80000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	0	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11503000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	9893000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2000	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-232000	usd
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-7000	usd
CY2023Q1	cbfv	Gain Loss On Purchase Of Tax Credits GainLossOnPurchaseOfTaxCredits	7000	usd
CY2022Q1	cbfv	Gain Loss On Purchase Of Tax Credits GainLossOnPurchaseOfTaxCredits	14000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	11000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	140000	usd
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	136000	usd
CY2023Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	302000	usd
CY2022Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	0	usd
CY2023Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	69000	usd
CY2022Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	65000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	2810000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	2613000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5079000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4565000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	701000	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	686000	usd
CY2023Q1	us-gaap	Equipment Expense EquipmentExpense	218000	usd
CY2022Q1	us-gaap	Equipment Expense EquipmentExpense	210000	usd
CY2023Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	857000	usd
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	485000	usd
CY2023Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	152000	usd
CY2022Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	209000	usd
CY2023Q1	us-gaap	Taxes Other TaxesOther	260000	usd
CY2022Q1	us-gaap	Taxes Other TaxesOther	240000	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	147000	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	587000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	182000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	152000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	79000	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	116000	usd
CY2023Q1	cbfv	Other Real Estate Owned Income Expense OtherRealEstateOwnedIncomeExpense	37000	usd
CY2022Q1	cbfv	Other Real Estate Owned Income Expense OtherRealEstateOwnedIncomeExpense	38000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	445000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	445000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	945000	usd
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	999000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	9028000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	8656000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5285000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3850000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1129000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	803000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5109597	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5198194	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5115705	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5220887	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	2580000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-12351000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax	557000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax	-2660000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2023000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9691000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6179000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6644000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	110155000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2023000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	174000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5834	shares
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	130000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.25
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1275000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117195000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133124000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9691000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	130000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	167000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	131840	shares
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3383000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.24
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1238000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	122156000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-22000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-17000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	710000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	637000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	80000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-232000	usd
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-7000	usd
CY2023Q1	cbfv	Gain Loss On Purchased Tax Credits GainLossOnPurchasedTaxCredits	7000	usd
CY2022Q1	cbfv	Gain Loss On Purchased Tax Credits GainLossOnPurchasedTaxCredits	14000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	140000	usd
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	136000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	140000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	0	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	138000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	0	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2000	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	1000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	174000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	130000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	33000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-94000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	11000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1129000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	956000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	109000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-810000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1640000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7231000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3165000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3359000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	8328000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	26826000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	15865000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-223000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	204000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	36000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
CY2023Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1392000	usd
CY2022Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	37000	usd
CY2023Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-223000	usd
CY2022Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	26000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11059000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18450000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	13017000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	23700000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-7939000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-47000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1275000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1238000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	130000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3383000	usd
CY2023Q1	cbfv	Proceeds From Payments For Stock Options Exercised ProceedsFromPaymentsForStockOptionsExercised	0	usd
CY2022Q1	cbfv	Proceeds From Payments For Stock Options Exercised ProceedsFromPaymentsForStockOptionsExercised	167000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3673000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19199000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-155000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3914000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103700000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119674000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103545000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	123588000	usd
CY2023Q1	cbfv	Interest Expense And Accrued Interest On Deposit Accounts InterestExpenseAndAccruedInterestOnDepositAccounts	2540000	usd
CY2022Q1	cbfv	Interest Expense And Accrued Interest On Deposit Accounts InterestExpenseAndAccruedInterestOnDepositAccounts	616000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2552000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	486000	usd
CY2023Q1	cbfv	Proceeds Receivable From Claims On Bank Owned Life Insurance ProceedsReceivableFromClaimsOnBankOwnedLifeInsurance	1392000	usd
CY2022Q1	cbfv	Proceeds Receivable From Claims On Bank Owned Life Insurance ProceedsReceivableFromClaimsOnBankOwnedLifeInsurance	0	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	248000	usd
CY2022Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	usd
CY2023Q1	cbfv	Syndicated Loans Purchased Not Settled SyndicatedLoansPurchasedNotSettled	8943000	usd
CY2022Q1	cbfv	Syndicated Loans Purchased Not Settled SyndicatedLoansPurchasedNotSettled	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	77000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1175000	usd
CY2023Q1	cbfv	Lease Liability Recognized LeaseLiabilityRecognized	75000	usd
CY2022Q1	cbfv	Lease Liability Recognized LeaseLiabilityRecognized	1175000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5109597	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5198194	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6108	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	22693	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5115705	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5220887	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q1	cbfv	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest	217427000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	30869000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	186559000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2466000	usd
CY2023Q1	us-gaap	Trading Securities TradingSecurities	189025000	usd
CY2022Q4	cbfv	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest	220808000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	33448000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	187360000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2698000	usd
CY2022Q4	us-gaap	Trading Securities TradingSecurities	190058000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	57	security
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	26319000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	960000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	56	security
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	159697000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	29909000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	113	security
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	186016000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	30869000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	82	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	62435000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5857000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	32	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	124925000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	27591000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	114	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	187360000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	33448000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-232000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	245000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	245000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	23554000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	21204000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	60797000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	52746000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	132831000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	112364000	usd
CY2023Q1	cbfv	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest	217427000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	186559000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-7000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-232000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-7000	usd
CY2023Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-232000	usd
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-7000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1071865000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1049873000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	10270000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	12819000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1061595000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1037054000	usd
CY2023Q1	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1300000	usd
CY2022Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1200000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	56301000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	226898000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	195843000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	145263000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	115069000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	297446000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	35045000	usd
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1071865000	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteOff	0	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteOff	22000	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteOff	7000	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteOff	0	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteOff	0	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Write Off FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteOff	8000	usd
CY2023Q1	cbfv	Financing Receivable Excluding Accrued Interest Revolving Write Off FinancingReceivableExcludingAccruedInterestRevolvingWriteOff	16000	usd
CY2023Q1	cbfv	Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Write Off FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessWriteOff	53000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1049873000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	5413000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1071865000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	3998000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1049873000	usd
CY2023Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	33000	usd
CY2022Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	79000	usd
CY2023Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	855000	usd
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	1400000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	12819000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	53000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	809000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	80000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	10270000	usd
CY2022Q4	cbfv	Financing Receivable Excluding Accrued Interest Allowance For Credit Losses Individually Evaluated For Impairment FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossesIndividuallyEvaluatedForImpairment	24000	usd
CY2022Q4	cbfv	Financing Receivable Excluding Accrued Interest Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12795000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	11582000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	37000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	50000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	0	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	11595000	usd
CY2022Q1	cbfv	Financing Receivable Excluding Accrued Interest Allowance For Credit Losses Individually Evaluated For Impairment FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossesIndividuallyEvaluatedForImpairment	180000	usd
CY2022Q1	cbfv	Financing Receivable Excluding Accrued Interest Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	11415000	usd
CY2022Q4	cbfv	Financing Receivable Excluding Accrued Interest Individually Evaluated For Impairment FinancingReceivableExcludingAccruedInterestIndividuallyEvaluatedForImpairment	15089000	usd
CY2022Q4	cbfv	Financing Receivable Excluding Accrued Interest Collectively Evaluated For Impairment FinancingReceivableExcludingAccruedInterestCollectivelyEvaluatedForImpairment	1034784000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1049873000	usd
CY2022Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	487000	usd
CY2023Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	61000	usd
CY2023Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	426000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	13474000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	13908000	usd
CY2022	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	13150000	usd
CY2022	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	654000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	1615000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	24000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	1615000	usd
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	2037000	usd
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	116000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15089000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	24000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	15523000	usd
CY2022	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15187000	usd
CY2022	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	770000	usd
CY2023Q1	cbfv	Increase Decrease In Impaired Financing Receivable Recorded Investment IncreaseDecreaseInImpairedFinancingReceivableRecordedInvestment	-1400000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	1600000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	24000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	169248000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	156666000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	77000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	82000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	7000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	7000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	84000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	89000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1864000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1926000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y11M19D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M17D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0287
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0287
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	359000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	347000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	248000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	233000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	231000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	832000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2250000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	237000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2013000	usd
CY2023Q1	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	151000	usd
CY2022Q1	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	131000	usd
CY2023Q1	us-gaap	Supplies Expense SuppliesExpense	54000	usd
CY2022Q1	us-gaap	Supplies Expense SuppliesExpense	80000	usd
CY2023Q1	us-gaap	Postage Expense PostageExpense	103000	usd
CY2022Q1	us-gaap	Postage Expense PostageExpense	103000	usd
CY2023Q1	us-gaap	Communication Communication	144000	usd
CY2022Q1	us-gaap	Communication Communication	139000	usd
CY2023Q1	cbfv	Charitable Contributions Expense CharitableContributionsExpense	34000	usd
CY2022Q1	cbfv	Charitable Contributions Expense CharitableContributionsExpense	42000	usd
CY2023Q1	cbfv	Dues And Subscriptions Expense DuesAndSubscriptionsExpense	79000	usd
CY2022Q1	cbfv	Dues And Subscriptions Expense DuesAndSubscriptionsExpense	58000	usd
CY2023Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	57000	usd
CY2022Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	127000	usd
CY2023Q1	cbfv	Meals And Entertainment Expense MealsAndEntertainmentExpense	15000	usd
CY2022Q1	cbfv	Meals And Entertainment Expense MealsAndEntertainmentExpense	30000	usd
CY2023Q1	cbfv	Travel Expense TravelExpense	54000	usd
CY2022Q1	cbfv	Travel Expense TravelExpense	39000	usd
CY2023Q1	cbfv	Training Expense TrainingExpense	33000	usd
CY2022Q1	cbfv	Training Expense TrainingExpense	18000	usd
CY2023Q1	cbfv	Bank Assessment Expense BankAssessmentExpense	52000	usd
CY2022Q1	cbfv	Bank Assessment Expense BankAssessmentExpense	47000	usd
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	74000	usd
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	62000	usd
CY2023Q1	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	95000	usd
CY2022Q1	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	123000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	945000	usd
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	999000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Assets Assets	1430708000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1313513000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117195000	usd
CY2022Q4	us-gaap	Assets Assets	1408938000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1298783000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	110155000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14244000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2661000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11583000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	80000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11503000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	2810000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	9028000	usd
CY2023Q1	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5285000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1129000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4156000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10616000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	723000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9893000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	0	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	9893000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	2613000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	8656000	usd
CY2022Q1	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3850000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	803000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3047000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	283748	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.52
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	61475	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.01
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	747	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.02
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	344476	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.06
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	189749	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.53
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M12D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	154727	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	23.49
CY2023Q1	cbfv	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P9Y3M18D
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	673000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	430000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1800000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1400000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001605301-23-000024-index-headers.html	Edgar Link	pending
0001605301-23-000024-index.html	Edgar Link	pending
0001605301-23-000024.txt	Edgar Link	pending
0001605301-23-000024-xbrl.zip	Edgar Link	pending
cbfv-20230331.htm	Edgar Link	pending
cbfv-20230331.xsd	Edgar Link	pending
cbfv-20230331_g1.jpg	Edgar Link	pending
currentcbfv-ex311ceocertif.htm	Edgar Link	pending
currentcbfv-ex312cfocertif.htm	Edgar Link	pending
cbfv-20230331_lab.xml	Edgar Link	unprocessable
cbfv-20230331_cal.xml	Edgar Link	unprocessable
cbfv-20230331_def.xml	Edgar Link	unprocessable
cbfv-20230331_pre.xml	Edgar Link	unprocessable
cbfv-20230331_htm.xml	Edgar Link	completed
currentcbfv-ex321ceoandcfo.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBFV
CB Financial Services, Inc. Stock $cbfv

2023 Q2 Form 10-Q Financial Statement

#000160530123000024 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBFV CB Financial Services, Inc. Stock $cbfv

2023 Q2 Form 10-Q Financial Statement

#000160530123000024 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBFV
CB Financial Services, Inc. Stock $cbfv